Hosted on MSN5mon
Sanofi and CD&R enter exclusive talks for Opella sale
Investing.com -- Sanofi (EPA:SASY)(NASDAQ ... in the consumer healthcare market and its portfolio includes well-known brands such as Allegra, Doliprane, and Dulcolax, catering to over 500 million ...
GlobalData on MSN1mon
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi also claims Opella is also the third-largest business in the world in the over-the-counter vitamins ... a GlobalData ...
Mena FN19d
OTC Consumer Health Market Positioned For Accelerated Growth With Johnson&Johnson, Abbott Laboratories, Sanofi, Unilever
The OTC Consumer Health Market report covers the Top Key Players. Johnson & Johnson, Abbott Laboratories, Sanofi, GlaxoSmithKline plc. Bayer AG, Nestle Company, Procter & Gamble Corp., Danone Food ...
pharmaphorum5y
Sanofi licenses OTC Tamiflu rights for the US market
Sanofi isn’t saying how much it is paying for the OTC rights to Tamiflu in the US ... as Tamiflu continues to decline, with the older brand reduced to just $179m in the first quarter of this ...
pharmaphorum5mon
Sanofi in talks to sell stake in consumer health spinout
It accounts for around 13% of Sanofi's total revenues and is reported to be the world's third-largest company in the over-the-counter medicines ... with a portfolio of 100 brands.
Warc1y
Allevia UK: 360 launch campaign
Sanofi is one of the biggest players in the Allergy category globally. But in the UK its portfolio was still underrepresented. Aware of a high level of dissatisfaction from UK allergy sufferers with ...